| 6501/13381 | US=9 / Urologia Phillips CK, Petrylak DP. Docetaxel. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 133-46. ISBN 978-1-60327-831-7. DOCETAXEL; QUIMIOTERAPIA; SOBREVIVENCIA; RESISTENTE A CASTRACAO CANCER DE PROSTATA |
| 6502/13381 | US=9 / Urologia Rosenberg J. Beyond Docetaxel: emerging agents in the treatment of advanced prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 147-51. ISBN 978-1-60327-831-7. DOCETAXEL; CANCER DE PROSTATA AVANCADO; INIBICAO DE MTOR; NOVAS TERAPEUTICAS; DESACETILACAO DAS HISTONAS; HSP90; FATOR 1 DE CRESCIMENTO COM INSULINA |
| 6503/13381 | US=9 / Urologia Brick A, Niu J, Huang J, Oh WK. Platinum agents in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 153-61. ISBN 978-1-60327-831-7. AGENTES DE PLATINA NO CANCER DE PROSTATA; CARBOPLATINA; NEUROENDOCRINO; RESISTENTE A CASTRACAO; QUIMIOTERAPIA |
| 6504/13381 | US=9 / Urologia Sissung TM, Figg WD. Clinical pharmacology and pharmacogenetics of chemotherapy in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 163-77. ISBN 978-1-60327-831-7. FARMACOGENETICA DA QUIMIOTERAPIA. CANCER DE PROSTATA; FARMACOLOGIA CLINICA; DOCETAXEL; MITOXANTRONA; ESTRAMUSTINA; SATRAPLATIN; CANCER DE PROSTATA; FARMACOGENETICA; FARMACOLOGIA |
| 6505/13381 | US=9 / Urologia Fojo AT, Adelberg DE. Microtubule targeting agents. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 179-94. ISBN 978-1-60327-831-7. CITOESQUELETO; MICROTUBULOS; TUBULINA; QUIMIOTERAPIA; CANCER DE PROSTATA |
| 6506/13381 | US=109 / Câncer Oh WK, Ross R, Choueiri TK, Kantoff PW, Corless C. Cancer of the genitourinary tract. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 233-77. ISBN 978-0-323-05905-3. CANCER DO TRATO GENITURINARIO; CANCER DE PROSTATA; CANCER DE BEXIGA; CANCER DE RIM; CANCER TESTICULAR; CANCER DE PENIS |
| 6507/13381 | US=9 / Urologia Chau CH, Figg WD. Principles of antiangiogenic therapy. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 197-205. ISBN 978-1-60327-831-7. TERAPIA ANTIANGIOGENICA; ANGIOGENESE; INTERRUPTOR ANGIOGENICO; INIBIDOR DA ANGIOGENESE; DENSIDADE MICROVASCULAR; ANTIANGIOGENICA TERAPIA |
| 6508/13381 | US=109 / Câncer Hirsch MS, Krag KJ, Matulonis UA. Gynecologic tumors and malignancies. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 278-324. ISBN 978-0-323-05905-3. CANCER GINECOLOGICO; CARCINOMA DE OVARIO; CANCER ENDOMETRIAL; CANCER CERVICAL; CARCINOMA VULVAR; CARCINOMA VAGINAL; CARCINOMA TROMPA DE FALOPIO; CARCINOMA PERITONEAL; NEOPLASIA TROFOBLASTICA GESTACIONAL |
| 6509/13381 | US=9 / Urologia Elfiky AA, Kelly WK. Bevacizumab in advanced prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 207-14. ISBN 978-1-60327-831-7. BEVACIZUMAB IN ADVANCED PROSTATE CANCER; ANGIOGENESE; CANCER DE PROSTATA; DROGAS; BEVACIZUMAB |
| 6510/13381 | US=109 / Câncer Chen WY, Campos SM, Hayes DF. Breast cancer. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 325-64. ISBN 978-0-323-05905-3. CANCER DE MAMA; CANCER DE MAMA. INCIDENCIA; CANCER DE MAMA. HISTOLOGIA; CANCER DE MAMA. DIAGNOSTICO; CANCER DE MAMA. TRATAMENTO; CANCER DE MAMA METASTATICO |
| 6511/13381 | US=9 / Urologia Gardner ER, Di Lorenzo G, Figg WD. Thalidomide and analogs. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 215-23. ISBN 978-1-60327-831-7. TALIDOMIDA; LENALIDOMIDA; ANGIOGENESE; CANCER DE PROSTATA; IMUNOMODULADORES |
| 6512/13381 | US=109 / Câncer Sadow PM, Socinski MA, Moore FD Jr. Endocrine neoplasia. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 365-402. ISBN 978-0-323-05905-3. NEOPLASIA ENDOCRINA; CANCER DA GLANDULA TIREOIDE; TUMOR DA GLANDULA ADRENAL; FEOCROMOCITOMA; PARAGANGLIOMA; TUMOR DA GLANDULA PITUITARIA; TUMORES NEUROENDOCRINOS; TUMORES DE CELULAS DA ILHOTA; SINDROMES DE NEOPLASIAS ENDOCRINAS MULTIPLAS |
| 6513/13381 | US=109 / Câncer George S, Hornick JL, Joste NE, Antman KH, Demetri GD. Sarcomas of soft tissue and bone and gastrointestinal stromal tumors. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 403-45. ISBN 978-0-323-05905-3. SARCOMAS DE TECIDOS MOLES; SARCOMAS OSSEOS; TUMORES ESTROMAIS GASTROINTESTINAIS; OSTEOSARCOMA; SARCOMA DE EDWING; CONDROSARCOMA; TUMOR DE CELULAS GIGANTES; CORDOMA; FIBROSARCOMA; LIPOSARCOMA; SARCOMA SINOVIAL; TUMOR MALIGNO DA BAINHA DE NERVO PERIFERICO; ANGIOSARCOMA; LEIOMIOSSARCOMA; SARCOMAS DO ESTROMA ENDOMETRIAL; RABDOMIOSARCOMA; TUMORES ESTROMAIS GASTRINTESTINAIS |
| 6514/13381 | US=109 / Câncer Friedlander P, Hodi FS, Wick MM, Velazquez EF. Skin cancer. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 446-83. ISBN 978-0-323-05905-3. CANCER DE PELE; CARCINOMA BASOCELULAR; CARCINOMA DE CELULAS ESCAMOSAS; QUERATOACANTOMA; MELANOMA |
| 6515/13381 | US=109 / Câncer Maher EA, Mckee AC. Neoplasms of the central nervous system. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 484-528. ISBN 978-0-323-05905-3. CANCER DO SISTEMA NERVOSO CENTRAL; TUMORES DE NERVOS CRANIANOS; TUMORES DA COLUNA VERTEBRAL; TUMORES DAS MENINGES; LINFOMAS; NEOPLASIAS HEMATOPOIETICAS; TUMORES DE CELULAS GERMINATIVAS (TCG); TUMORES DA REGIAO SELAR; TUMORES METASTATICOS |
| 6516/13381 | US=109 / Câncer Wadleigh M, Dorfman DM, Skarin AT. Acute and chronic leukemias. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 529-70. ISBN 978-0-323-05905-3. LEUCEMIA AGUDA; LEUCEMIA CRONICA; SINDROME MIELODISPLASICA; POLICITEMIA; MIELOFIBROSE; LEUCEMIA LINFOCITICA CRONICA; LEUCEMIA MIELOIDE CRONICA |
| 6517/13381 | US=109 / Câncer Jacobsen E, Dorfman DM, Skarin AT. Hodgkin disease and non-Hodgkin lymphomas. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 571-639. ISBN 978-0-323-05905-3. |
| 6518/13381 | US=109 / Câncer Raje N, Anderson KC, Dorfman DM, Skarin AT. Multiple myeloma and plasma cell dyscrasias. In: Skarin AT. Dana-Faber Cancer Institute: atlas of diagnostic oncology. 4ª ed. Philadelphia: Elsevier Mosby, 2010. p. 640-66. ISBN 978-0-323-05905-3. MIELOMA MULTIPLO; DISCRASIAS DE CELULAS PLASMATICAS; LEUCEMIA DE CELULAS PLASMATICAS; GAMOPATIA MONOCLONAL; MACROGLOBULINEMIA DE WALDENSTROM |
| 6519/13381 | US=9 / Urologia Aragon-Ching JB, Dahut W. Investigational angiogenesis inhibitors. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 225-32. ISBN 978-1-60327-831-7. INIBIDORES DA ANGIOGENESE; ANTIANGIOGENESIS; ENSAIOS CLINICOS; CANCER DE PROSTATA; TIROSINA QUINASES |
| 6520/13381 | US=9 / Urologia Bocci G, Pasqualetti G, Di Paolo A, Crea F, Del Tacca M, Danesi R. Pharmacogenetics of angiogenesis. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 233-42. ISBN 978-1-60327-831-7. TERAPIA ANTIANGIOGENESIS; RISCO DE CANCER; POLIMORFISMOS DE NUCLEOTIDEO UNICO; HIF; MMP; TNF; VEGF |